Oxford BioTherapeutics
Latest round
- Series B
Last raised
- Mar 2005
Total raised
- $0.8M
Investors
- 2
About Oxford BioTherapeutics
Founded in 2004 in Abingdon, UK, Oxford BioTherapeutics Ltd develops first-in-class cancer therapies.2 mn.022 mn.Oxford BioTherapeutics focuses on developing first-in-class cancer therapies through its innovative product offerings, which include Antibody-Drug Conjugates (ADCs), Immuno-oncology treatments, T-Cell Engagers (TCEs), and radiopharmaceuticals. The company leverages its proprietary OGAP®-Verify platform, a high-sensitivity proteomic technology that identifies novel cancer-specific targets.20.Oxford BioTherapeutics is focused on expanding its product line and growth into new markets. Additionally, Oxford BioTherapeutics is looking to increase its presence in North America and Europe, targeting partnerships that will facilitate access to broader markets.
Who invested in Oxford BioTherapeutics
2 investors across 1 round
See all investors in Oxford BioTherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 30, 2005
Amount
$0.8M
Investors
Questions about Oxford BioTherapeutics
Who invested in Oxford BioTherapeutics?
Oxford BioTherapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oxford BioTherapeutics raised?
Oxford BioTherapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oxford BioTherapeutics last raise money?
Oxford BioTherapeutics's most recent round on record is a Series B, in Mar 2005.
What does Oxford BioTherapeutics do?
Founded in 2004 in Abingdon, UK, Oxford BioTherapeutics Ltd develops first-in-class cancer therapies.
Where is Oxford BioTherapeutics headquartered?
Oxford BioTherapeutics is headquartered in Abingdon, UK.
Which VCs invest in companies like Oxford BioTherapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Oxford BioTherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Oxford BioTherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.